Overview of Cystic Fibrosis' and Non-CF Bronchiectasis

Seminars in Respiratory and Critical Care Medicine

Volumn 24, Issue 6, 2003, Pages 619-627

  Rubin, Bruce K ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; DORNASE ALFA; ERYTHROMYCIN; IBUPROFEN; STEROID; SURFACTANT; TRANSMEMBRANE CONDUCTANCE REGULATOR; TROLEANDOMYCIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ATELECTASIS; AZOOSPERMIA; BRONCHIECTASIS; BRONCHIOLITIS; BRONCHOPULMONARY ASPERGILLOMA; BRONCHUS; BRONCHUS OBSTRUCTION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COR PULMONALE; COUGHING; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; EDITORIAL; GENE REPLACEMENT THERAPY; HAEMOPHILUS INFLUENZAE; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPERTRANSLUCENT LUNG; IMMUNE DEFICIENCY; LOWER RESPIRATORY TRACT INFECTION; MEDICAL LITERATURE; MIDDLE LUNG LOBE SYNDROME; NONHUMAN; NUTRITION; PERTUSSIS; PHYSIOTHERAPY; PRIORITY JOURNAL; PROPHYLAXIS; PUBLICATION; RESPIRATORY FAILURE; RISK FACTOR; SACCULAR BRONCHIECTASIS; SIDE EFFECT; SOCIAL PSYCHOLOGY; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SWEAT TEST; THORAX RADIOGRAPHY; TUBULAR BRONCHIECTASIS; VARICOSE BRONCHIECTASIS; WILLIAMS BEUREN SYNDROME; YELLOW NAIL SYNDROME;

EID: 0347656779     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815658     Document Type: Editorial

References (26)

1. Barker AF, Bardana EJ Jr. Bronchiectasis: Update of an orphan disease. Am Rev Respir Dis 1988;137:969-978
2. Stanford W, Galvin JR. The diagnosis of bronchiectasis. Clin Chest Med 1988;9:691-699
3. Pang JA, Hamilton-Wood C, Metreweli C. The value of computed tomography in the diagnosis and management of bronchiectasis. Clin Radiol 1989;40:40-44
4. Verra F, Escudier E, Bignon J, et al. Inherited factors in diffuse bronchiectasis in the adult: a prospective study. Eur Respir J 1991;4:937-944
5. Leigh MW. Primary ciliary dyskinesia. Semin Respir Crit Care Med 2003;24:653-662
6. Bush A, Rubin BK. Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis. Semin Respir Crit Care Med 2003;24:737-748
7. Wilson JF, Decker AM. The surgical management of childhood bronchiectasis. Ann Surg 1982;195:354-363
8. Davis PB, Drumm M, Konstan MW. State of the art: cystic fibrosis. Am J Respir Crit Care Med 1996;154:1229-1256
9. Gallati S. Genetics of cystic fibrosis. Semin Respir Crit Care Med 2003;24:629-638
10. Rosenstein BJ. Cystic fibrosis. In: Loughlin GM, Eigen H, eds. Respiratory Disease in Children: Diagnosis and Management. 1st ed. Baltimore: Williams & Wilkins; 1994:263-289
11. Ramsey BW, Farrell PM, Pencharz P, et al. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992;55:108-116
12. Currie AJ, Speert DP, Davidson DJ. Pseudomonas aeruginasa: role in the pathogenesis of the CF lung lesion. Semin Respir Crit Care Med 2003;24:671-680
13. Jackson K, Kayser R, Wozniak DJ. The role of biofilms in airway disease. Semin Respir Crit Care Med 2003;24:663-670
14. Sexauer WP, Fiel SB. Aerosolized antibiotics in cystic fibrosis. Semin Respir Crit Care Med 2003;24:717-726
15. Nick JA. Nontuberculous mycobacteria in cystic fibrosis. Semin Respir Crit Care Med 2003;24:693-702
16. LiPuma JJ. Burkholderia and emerging pathogens in cystic fibrosis. Semin Respir Crit Care Med 2003;24:681-692
17. Frederiksen B, Koch C, Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-335
18. Koch C, Frederiksen B, Høiby N. Patient cohorting and infection control. Semin Respir Crit Care Med 2003;24:703-716
19. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995;332:848-854
20. van der Schans CP, de Jong W, Rubin BK. Chest physical therapy: Assessment of techniques. Clin Pulm Med 1996;3:179-184
21. Flume PA. Airway clearance techniques. Semin Respir Crit Care Med 2003;24:727-736
22. Ramsey BW, Astley SJ, Aitken ML, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994;331:637-642
23. Rubin BK. Cystic fibrosis: bench to bedside 2003. Can Respir J 2003;10:161-164
24. Sweet SC, Spray TL, Huddleston CB, et al. Pediatric lung transplantation at St. Louis Children's Hospital, 1990-1995. Am J Respir Crit Care Med 1997;155:1027-1035
25. Weiss DJ, Pilewski JM. The status of gene therapy for cystic fibrosis. Semin Respir Crit Care Med 2003;24:749-770
26. Schechter MS. Nongenetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and health care interventions. Semin Respir Crit Care Med 2003;24:639-652